RAPT Therapeutics Inc

RAPT NASDAQ Santé & Biotech États-Unis
58.02 $

RAPT Therapeutics développe des médicaments immuno-oncologiques destinés au traitement de cancers et de maladies inflammatoires.

Performance & Momentum

6 Months 336.78 %
1 Year 547.38 %
3 Years 75.67 %
5 Years 57.12 %

Similar stocks to RAPT Therapeutics Inc

Anantys Community

Be the first to share your analysis on RAPT Therapeutics Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases